This is a routine business development announcement with no immediate financial data. Monitor future 10-Q or 10-K filings for any revenue contribution or cost impact from this program. No trading action warranted based on this filing alone.
Price Chart
Executive Summary
ZEO ScientifiX announced the formal launch of its Physician-Led Patient Masterclass program, a patient education initiative for regenerative medicine. The program is based on a grassroots model that emerged in Vero Beach, Florida, and follows the company having trained more than 600 physicians in the past year. No financial terms, revenue guidance, or material financial impact were disclosed.
Key Facts
- Program formalizes a patient education model that originated organically in Vero Beach, Florida
- Company has trained more than 600 physicians across the Southeast in the past year
- Program targets three indications permitted under Florida law: pain management, wound care, and orthopedics
- No financial terms, costs, revenue projections, or material financial data disclosed in the filing
- Press release dated May 27, 2026
Financial Impact
No financial terms or expected revenue impact disclosed
Risk Factors
- Patient education program may not drive meaningful revenue growth
- Regulatory environment for regenerative medicine in Florida could change
- Forward-looking statements about demand and scaling carry no guarantees
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001829126-26-005695 |
| Document: zeoscientifix_ex99-1.htm | 0001829126-26-005695 |
| Document: 0001829126-26-005695-index-headers.html | 0001829126-26-005695 |
| Document: 0001829126-26-005695-index.html | 0001829126-26-005695 |
| Document: 0001829126-26-005695.txt | 0001829126-26-005695 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $1.48 | awaiting T+20 | — | $1.18 (−20.27%) |
Sep 15, 2026 6w ago | 8-K | $1.36 $1.15 | ▼ −15.44% | ▼ −18.42% | $1.18 (−13.24%) |
Sep 1, 2026 8w ago | 8-K | $1.20 $1.39 | ▲ +15.83% | ▲ +14.65% | $1.18 (−1.67%) |
Aug 4, 2026 12w ago | 8-K | $1.40 $1.20 | ▼ −14.16% | ▼ −12.93% | $1.18 (−15.59%) |
Jul 21, 2026 14w ago | 8-K | $1.69 $1.55 | ▼ −8.28% | ▼ −10.85% | $1.18 (−30.18%) |
Jul 8, 2026 15w ago | 8-K | $1.80 $1.40 | ▼ −22.33% | ▼ −25.61% | $1.18 (−34.44%) |
Jul 1, 2026 16w ago | 8-K | $1.77 $1.65 | ▼ −6.78% | ▼ −4.59% | $1.18 (−33.33%) |
Jun 16, 2026 19w ago | 8-K | $1.72 $1.94 | ▲ +12.79% | ▲ +11.93% | $1.18 (−31.40%) |
Jun 9, 2026 20w ago | 8-K | $1.67 $1.80 | ▲ +7.78% | ▲ +6.39% | $1.18 (−29.34%) |
May 27, 2026 21w ago | 8-K | $1.85 $1.70 | ▼ −8.11% | ▼ −6.21% | $1.18 (−36.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers